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The notential benefits of combination thrombolytic - r 
agents in the treatment of myocardial infarction (HI1 
remain uncertain. In a aall pilot study, we demonstrated 
that co&ining half dose tPA with streptokinase (SK) 
achieved a high rate of infarct vessel patency and a low 
rate of reocclusion at half the cost of full dose tPA. 
Therefore we designed a prospective trial in which 
patients within 6 hrs of HI are being ran&mired to full 
do:e tPA (100 mg/3hrl or the combination of half dose tPA 
(50 mg) with SK (1.5 kill) over 1 hr. Emergency coronary 
arteriography is performed to determine infarct vessel 
patency at 9D min with angioplasty reserved for failed 
thrombolysis only. Heparin ano aspirin are maintained 
until follow-up catheterization at day 7. Primary 
endpoints include patency, change in LW function, and 
bleeding complications. 
To date, 157 of 200 patients have been enrolled at e 
lllean tin@ of 2.9+1.2 hr of symptom onset. Overall, infarct 
vessel patency hsis been established in 108 (69%) after 
oiytic therapy and in 151 (96%) with the additional 
use of PTCA. In-hospital mortality (5X), reocclusion (6%), 
and the incidence of significant bleeding reauirins 
transfusion (13%) have &en low. Recruitint 
completed and final results available by March 1990. These 
results will provide information regarding whether an 
inexpensive regimen of canbination half dose tPA with SK 
may be used in place of conventional full dose tPA. 
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altorations in vrclculrr well resulting from 
intemmntionel therapy, such as cracka, diabectionb, 
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